Vivos Therapeutics Inc. is a medical technology company that specializes in providing innovative solutions for the treatment of obstructive sleep apnea (OSA) and other sleep-related disorders. The company was founded in 2016 and is headquartered in Denver, Colorado, USA. Vivos was established with the mission to address the significant unmet need for effective, non-invasive treatments for sleep apnea, a condition that affects millions of people worldwide.
Obstructive sleep apnea is a serious sleep disorder where a person's breathing repeatedly stops and starts during sleep due to blocked or narrowed airways. It can lead to various health issues, including fatigue, hypertension, heart problems, and impaired cognitive function. Vivos Therapeutics aims to improve patient outcomes and quality of life by providing innovative treatment options that target the underlying causes of sleep apnea.
Vivos' proprietary technology and treatment approach involve the use of oral appliances, known as the Vivos System. These custom-made devices are designed to enhance the upper airway and promote proper breathing during sleep. By addressing the anatomical issues that contribute to sleep apnea, the Vivos System offers a non-surgical, non-pharmaceutical option for patients seeking relief from their sleep-related breathing disorders.
In addition to its focus on treating obstructive sleep apnea, Vivos Therapeutics continues to invest in research and development to expand its product offerings and explore new applications for its technology. With a growing market for sleep disorder treatments and increasing awareness of the impact of sleep apnea on overall health, Vivos is positioned to play a significant role in advancing the field of sleep medicine.